Literature DB >> 9485207

Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.

S B Joseph1, K T Miner, M Croft.   

Abstract

The role of antigen-presenting cell (APC)-derived cytokines in T cell activation is still controversial. Highly purified CD4 T cell populations of the naive and short-term Th1 and Th2 effector subsets were examined. Stimulation from anti-CD3 in the absence of APC was used to analyze directly T occurring cell-mediated effects, and the requirement for co-signaling was addressed using anti-CD28. Exogenous IL-6, IL-1 and TNF each enhanced proliferation and IL-2 secretion from naive cells, although IL-6 was most active in this regard. Peak responses, however, were obtained with IL-1 or TNF in combination with IL-6 resulting in up to 11-fold increases in IL-2 secretion. Enhanced naive T cell responses were only observed with anti-CD3 and anti-CD28, suggesting that co-signaling through surface-bound receptors was required to initiate IL-2 production. Although the cytokines enhanced naive activation, little effect was seen on differentiation into effector populations. IL-6 alone, or in combination, partially suppressed effectors secreting IFN-gamma, but did not promote generation of effectors secreting IL-4. In contrast to reports on cloned cell lines, IL-6, TNF and IL-1 had enhancing activities on all cytokines elicited from already generated Th1 and Th2 effector populations. Again combinations of IL-6, TNF and IL-1 were most effective and generally required CD28 signaling. Induced responses with preexisting effector cells were far less than with naive cells and predominantly directed at augmenting IFN-gamma and IL-5 secretion rather than IL-2 and IL-4. These studies show that APC-derived cytokines can promote T cell responses directly but largely after co-stimulation from accessory molecule co-receptors, that the effect is not specific for one T cell subset or cytokine, and that the naive T cell is the main target of action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485207     DOI: 10.1002/(SICI)1521-4141(199801)28:01<277::AID-IMMU277>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Deregulated cytokine network and defective Th1 immune response in multiple myeloma.

Authors:  M A Frassanito; A Cusmai; F Dammacco
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1β production from monocytes in humans.

Authors:  Won-Woo Lee; Naeun Lee; Hajime Fujii; Insoo Kang
Journal:  Cell Immunol       Date:  2012-04-06       Impact factor: 4.868

3.  Dietary supplementation with tocotrienols enhances immune function in C57BL/6 mice.

Authors:  Zhihong Ren; Munkyong Pae; Maria Carlota Dao; Donald Smith; Simin Nikbin Meydani; Dayong Wu
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

Review 4.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

5.  Beryllium, an adjuvant that promotes gamma interferon production.

Authors:  J Y Lee; O Atochina; B King; L Taylor; M Elloso; P Scott; M D Rossman
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery.

Authors:  C Witschi; R J Mrsny
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

7.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.

Authors:  A Porgador; H F Staats; Y Itoh; B L Kelsall
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism.

Authors:  M Ulanova; A Tarkowski; M Hahn-Zoric; L A Hanson
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.

Authors:  Nicholas T Funderburg; Samantha R Stubblefield Park; Hannah C Sung; Gareth Hardy; Brian Clagett; James Ignatz-Hoover; Clifford V Harding; Pingfu Fu; Jeffry A Katz; Michael M Lederman; Alan D Levine
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.